Comparative Study of p53 Mutations in Breast Cancer
Author Information
Author(s): G Chakravarty, A Redkarl, I Mittra
Primary Institution: Tata Memorial Hospital
Hypothesis
How closely do p53 mutations detected by different methods correlate with each other?
Conclusion
The study found good concordance between mutations detected by PCR-SSCP and genomic sequencing, but immunochemical detection of p53 overexpression is not a reliable indicator of p53 gene mutation.
Supporting Evidence
- 64% of the breast tumors were found to be immunopositive for p53.
- 11 out of 15 immunopositive tumors had mutations detected by PCR-SSCP.
- 96.5% concordance was found between PCR-SSCP and genomic sequencing.
Takeaway
Scientists looked at breast cancer samples to see if a protein called p53 was mutated. They found that just because the protein was present, it didn't always mean there was a mutation.
Methodology
The study used flow cytometry, PCR-SSCP, and genomic sequencing to analyze p53 mutations in breast cancer tissues.
Limitations
The study's findings may not apply to all breast cancer cases, as it focused on a specific subset of tumors.
Want to read the original?
Access the complete publication on the publisher's website